WAX.ASX
Wam Research Ltd
https://www.marketindex.com.au/asx/wax/financials
Annual Financial Summary
06/2023
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
06/2016
06/2015
06/2014
Profitability
NPAT ($)
16,854,237
(20,698,660)
NPAT Margin
--
--
Abnormals ($)
-
-
NPAT before Abnormals ($)
16,854,237
(20,698,660)
Return on Equity (ROE)
8.46%
-10.41%
Return on Assets (ROA)
8.28%
-10.12%
Valuation
PE Ratio
12.54
(12.31)
PE Relative to Market
100.4%
0.0%
Price to Book
1.07
1.29
Price to Cash Flow
13.77
(11.77)
Shares Outstanding (M)
200.89
198.04
Market Cap ($M)
$212.94
$256.46
Enterprise Value ($M)
$201.73
$218.83
Performance
Total Shareholder Return
-11.3%
-16.5%
Relative to Market
-26.1%
-9.0%
Per Share
Earnings (EPS Adjusted)
8.45
-10.52
Earnings (with Abnormals)
8.45
-10.52
Cash Flow
(5.10)
22.70
Cash
0.06
0.19
Net Tangible Assets
0.99
1.00
Book Value
0.99
1.00
Share Price
$1.06
$1.29
Liquidity
Quick Ratio
42.60
32.75
Current Ratio
42.60
32.75
Efficiency
Asset Turnover
0.00
0.00
Inventory Turnover
-
-
Working Capital Turnover
0.00
0.00
Dividends
DPS (c)
10.00
10.00
Dividend yield
9.43%
7.72%
Franking
80%
100%
Gross DPS (c)
13.43
14.29
Gross Dividend Yield
12.67%
11.03%
Payout Ratio
118%
-
Member Content
Source:
Annual Financial Income Statement
06/2023
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
06/2016
06/2015
06/2014
Revenue from Operations
Investment Income
25,789,384
(27,635,077)
Other Income
-
14,566
Expenses
(3,143,465)
(3,446,197)
Profit / Loss before income tax
22,645,919
(31,066,708)
Tax Expense
(5,791,682)
10,368,048
NPAT before Abnormals
16,854,237
(20,698,660)
Abnormals
-
-
Abnormals Tax
-
-
Net Abnormals
-
-
Outside Equity
-
-
Preference Dividends
-
-
Reported NPAT after Abnormals
16,854,237
(20,698,660)
EQUITY
Share End
200,885,140
198,038,747
Share Weighted
199,360,594
196,710,006
Ordinary Dividends
(20,015,846)
(19,748,328)
EPS Adjusted
84,500
(105,200)
EPS after Abs
84,541
(105,224)
Equity Profit / Loss
-
-
Member Content
Source:
Annual Financial Balance Sheet
06/2023
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
06/2016
06/2015
06/2014
CURRENT ASSETS
Cash and Cash Equivalents
11.21
37.63
Receivables
4.72
3.3
Investments
172.61
144.93
Other Current Assets
-
-
Total Current Assets
188.54
185.85
NON-CURRENT ASSETS
Investments
1.43
1.8
Property
-
-
Other Non-Current Assets
13.59
16.84
Total Non-Current Assets
15.02
18.65
TOTAL ASSETS
203.56
204.5
CURRENT LIABILITIES
Creditors
2.75
3.35
Provisions
1.68
2.32
Other Liabilities
-
-
TOTAL CURRENT LIABILITIES
4.43
5.68
NON-CURRENT LIABILITIES
Borrowings
-
-
Deferred Tax
-
-
Other Non-Current Liabilities
-
-
TOTAL NON-CURRENT LIABILITIES
-
-
TOTAL LIABILITIES
4.43
5.68
NET ASSETS
207.99
210.18
Total Equity Attr. to Holders
199.14
198.83
Outside Equity
-
-
TOTAL EQUITY
199.14
198.83
Member Content
Source:
Annual Financial Cash Flow
06/2023
06/2022
06/2021
06/2020
06/2019
06/2018
06/2017
06/2016
06/2015
06/2014
CASH FLOWS FROM OPERATING ACTIVITIES
Receipts
432.64
450
Payments
(444.47)
(395.78)
Funds from Operations
-
-
Dividends Received
5.23
4.27
Interest Received
0.55
0.07
Interest Paid
-
-
Tax Paid
(3.07)
(7.73)
Other Operating Cash
(1.02)
(6.15)
NET CASH FROM OPERATING ACTIVITIES
(10.13)
44.68
CASH FLOWS FROM INVESTING ACTIVITIES
Receipts
-
-
Payments
-
-
PP&E
-
-
Proceeds PP&E
-
-
Purchase Subsidiary
-
-
Proceeds Subsidiary
-
-
Loans Granted
-
-
Loans Repaid
-
-
Other Investing Cash
-
-
NET CASH FROM INVESTING ACTIVITIES
-
-
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from Issue
-
-
Proceeds from Borrowings
-
-
Borrowings
-
-
Dividends Paid
(16.29)
(15.89)
Other Financing Cash
-
-
NET CASH FROM FINANCING ACTIVITIES
(16.29)
(15.89)
NET CHANGE IN CASH
(26.42)
28.79
CASH AT START
37.63
8.84
Exchange Rate Adjustment
-
-
Other Cash Adjustment
-
-
CASH AT END
11.21
37.63
Member Content
Source: